» Articles » PMID: 17096498

Extensively Drug-resistant Tuberculosis (XDR-TB): Recommendations for Prevention and Control

Overview
Date 2006 Nov 14
PMID 17096498
Citations 54
Affiliations
Soon will be listed here.
Citing Articles

Genomic, phenotypic and demographic characterization of in Israel in 2021.

Losev Y, Rubinstein M, Nissan I, Haviv P, Barsky Y, Volinsky M Front Cell Infect Microbiol. 2023; 13:1196904.

PMID: 37928179 PMC: 10622789. DOI: 10.3389/fcimb.2023.1196904.


HIV-Negative Rifampicin Resistance/Multidrug-Resistant Extrapulmonary Tuberculosis in China from 2015 to 2019: A Clinical Retrospective Investigation Study from a National Tuberculosis Clinical Research Center.

Ma J, Liu H, Wang J, Li W, Fan L, Sun W Infect Drug Resist. 2022; 15:1155-1165.

PMID: 35340674 PMC: 8943829. DOI: 10.2147/IDR.S342744.


Characteristics of tuberculosis patients in the integrated tuberculosis control model in Chongqing, China: a retrospective study.

Zhang L, Xing W, Zhou J, Zhang R, Cheng Y, Li J BMC Infect Dis. 2020; 20(1):576.

PMID: 32758169 PMC: 7404911. DOI: 10.1186/s12879-020-05304-z.


Computerised tomography scan in multi-drug-resistant versus extensively drug-resistant tuberculosis.

Mehrian P, Farnia P, Jalalvand D, Chamani M, Bakhtiyari M Pol J Radiol. 2020; 85:e39-e44.

PMID: 32180853 PMC: 7064012. DOI: 10.5114/pjr.2020.93123.


Attributable mortality from extensively drug-resistant gram-negative infections using propensity-matched tracer antibiotic algorithms.

Kadri S, Strich J, Swihart B, Hohmann S, Dekker J, Palmore T Am J Infect Control. 2019; 47(9):1040-1047.

PMID: 30824387 PMC: 6710115. DOI: 10.1016/j.ajic.2019.01.010.